The complete story of less than complete responses: The evolution and application of acute myeloid leukemia clinical responses
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference69 articles.
1. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges;Shallis;Blood Rev,2019
2. Revised recommendations of the international working Group for Diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia;Cheson;J Clin Oncol,2003
3. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council’s Adult and Childhood Leukaemia Working Parties;Wheatley;Br J Haematol,1999
4. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial;Kern;Blood.,2003
5. Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy;Oh;Ann Hematol,2017
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML;Blood Advances;2024-09-24
2. Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia;Annals of Hematology;2024-09-07
3. Relationship between morphologic remission with or without hematologic recovery and outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia;Bone Marrow Transplantation;2024-08-29
4. Outcomes by Best Response With Hypomethylating Agent Plus Venetoclax in Adults with Previously Untreated Acute Myeloid Leukemia;2024-03-15
5. Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts;Leukemia;2024-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3